| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.4M | +40.6% |
| Gross Profit | $27.0M | +43.8% |
| R&D Expense | $8.9M | +32.5% |
| SG&A Expense | $13.9M | +11.3% |
| Operating Income | -$39.0M | -32.4% |
| Interest Expense | $4.1M | +12.6% |
| Net Income | -$44.3M | -33.1% |
| EPS (Basic) | -$2.72 | -18.3% |
| EPS (Diluted) | -$2.72 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.0M | -4.4% |
| Accounts Receivable | $6.6M | +56.4% |
| Inventory | $11.8M | +54.0% |
| Current Assets | $62.4M | +5.7% |
| Total Assets | $67.9M | +8.5% |
| Current Liabilities | $12.4M | +17.3% |
| Long-term Debt | $39.9M | +26.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.7M | -33.9% |
| Capital Expenditures | $872K | +39.1% |
| Investing Cash Flow | -$1.9M | -198.6% |
| Financing Cash Flow | $40.9M | +6883.2% |
| Free Cash Flow | -$41.6M | -34.0% |
| -18.3% |
| Total Liabilities |
| $53.5M |
| +26.2% |
| Stockholders' Equity | $14.3M | -28.8% |